4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000107
President and CEO sold 4,523 shares at $4.51 ($20,399)
- President and CEO acquired 10,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2021-09-01 | Option exercise | +10,937 | 233,895 | D | ||
| Brunn Carsten President and CEO | 2021-09-02 | Sale | −4,523 | $4.51 | $20,399 | 229,372 | D |
| Derivatives | |||||||
| Brunn Carsten President and CEO | 2021-09-01 | Option exercise · Restricted Stock Units | −10,937 | 54,688 | D | ||
| Open-market sales · 4,523 sh · avg $4.51 · $20,399 | |||||||
Loading xslF345X03/wf-form4_163070026398370.xml…